Multiply Labs raises $20M to pioneer robotic manufacturing

By The Science Advisory Board staff writers

April 14, 2021 -- Multiply Labs has received $20 million in investments to pioneer the robotic manufacturing of individualized drugs.

The company was founded to leverage automation to address limitations of manual processes used to manufacture small-batch pharmaceutical products. Using autonomous technology, the company enables production of individualized drugs at industrial scale. It focuses on two markets: robotic manufacturing of personalized capsules for clinical trials and robotic manufacturing of cell therapies.

The series A financing, led by Casdin Capital, will support the deployment of cloud-controlled robotic systems to enable drug production at industrial scale.

Copyright © 2021

Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
American Society of Human Genetics Annual Meeting
October 25-29
Los Angeles, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter